Skip to main content
Public beta This website is in public beta – please give your feedback.

How do CNVs arise?

Although the mechanism is not fully understood, one theory is that during the complicated process of replication, chromosome sections can be either lost or duplicated due to unequal crossing over between homologous repetitive regions of DNA. This phenomenon is known as non-allelic homologous recombination.

Types of CNVs

The different types of CNV that can occur are:

Deletions and microdeletions result in loss of genetic material

Figure 1: Deletions and microdeletions result in loss of genetic material

Use in clinical context

CNVs are the second most common type of genomic variation, after structural number variants. They result in too much or too little protein being produced, which in turn can influence gene expression and/or contribute to disease.

Tumour cells often have structural variants that result in CNVs.

One of the most well-known examples of a disease-causing CNV is Huntingdon’s disease, which is caused by a repeating sequence of three base pairs (known as a trinucleotide repeat) at the end of the coding region of the HTT gene; people with 40 or more repeats are affected by Huntington’s disease.

CNVs at many recurrent genome hotspots are also associated with epilepsy.

Key messages

  • CNVs are regions of our genome that vary in the number of copies present, due to either duplication or deletion.
  • CNVs are classed as structural changes, and recent scientific research suggests that they may account for up to 9.5% of the human genome.
  • As well as contributing to normal genomic variation, CNVs can also contribute to disease or influence gene expression.

Resources

For clinicians

References: 

For patients

↑ Back to top
  • Last reviewed: 05/04/2023
  • Next review due: 05/04/2025
  • Authors: Dr Asma Hamad
  • Reviewers: Professor Barbara Jennings